(American Journal of Pathology) Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose. The related report by Yang et al., “Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry,” appears in the March 2010 issue of the Journal of Molecular Diagnostics.

Further information:

Article source

Related posts:

1. Warfarin Therapy And Personalized Medicine
2. Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data
3. Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept
4. Tech Council of Maryland to Host BioBreakfast Focusing on Commercial Implications of Personalized Medicine
5. Phadia Brings the First and Only Point of Care in Vitro Specific IgE Allergy Test Into the Physician’s Office With Final FDA Clearance of the ImmunoCAP(R) Rapid System